A study conducted in multiple centers across India to assess breathlessness in advanced cancer patients
Not Applicable
Completed
- Conditions
- Health Condition 1: D499- Neoplasm of unspecified behavior of unspecified site
- Registration Number
- CTRI/2021/10/037056
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 288
Inclusion Criteria
1. to have pathologically diagnosed cancer, and have been informed of their diagnosis
2. to have an advanced clinical stage or recurrence
3. to be 18 years or older
4. to be well enough to complete the questionnaire
5. to not to be suffering from severe mental or cognitive disorder
Exclusion Criteria
1. Patients with potential curable disease referred for early palliative care
2. Patients for whom reliable contact number or method of communication is not available
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Screen for clinical dyspnea as shown on a 100-mm visual analog scale and identify the clinical prevalence of dyspneaTimepoint: day 1
- Secondary Outcome Measures
Name Time Method Identify the quality of dyspnea by Cancer Dyspnea Scale (CDS)Timepoint: day 1, 3 and 7;To identify the effect of dyspnea management on daily life activities and quality of life of patients using EORTC QLQ-C15 pal.Timepoint: day 1, 3 and 7;To record the dosage of opioids/ 24 hours used to manage dyspnea in Oral Morphine Equivalents (OME) and changes in VAS -DTimepoint: day 1, 3 and 7